Digoxin
Brand name: Digoxin
Rank #465 of 500 drugs by total cost
$15.9M
Total Cost
548,410
Total Claims
$15.9M
Total Cost
18,331
Prescribers
$29
Cost per Claim
70,405
Beneficiaries
1,097,961
30-Day Fills
$868
Avg Cost/Provider
30
Avg Claims/Provider
About Digoxin
Digoxin (sold as Digoxin) was prescribed 548,410 times by 18,331 Medicare Part D providers in 2023, costing the program $15.9M. At $29 per claim, this is a relatively affordable medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 462 | Nivolumab (Opdivo) | $16.0M | 1,275 |
| 463 | Leflunomide (Leflunomide) | $16.0M | 205,765 |
| 464 | Hydrocortisone (Hydrocortisone) | $15.9M | 762,398 |
| 465 | Digoxin (Digoxin) | $15.9M | 548,410 |
| 466 | Alpelisib (Piqray) | $15.7M | 747 |
| 467 | Doxazosin Mesylate (Doxazosin Mesylate) | $15.7M | 729,878 |
| 468 | Prucalopride Succinate (Motegrity) | $15.7M | 22,068 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology